In fact, we have previously shown in an immunodeficient GBM mouse model treated with CAR T cells that, compared to control tumors, tumors with silenced INCR1 presented a higher number of CD4 + T cells infiltrated and reduced expression of PD-1 in CD8 + T cells [19]. The gene discussed is INCR1; the disease is glioblastoma.